At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Erythropoietin Gel as an Adjunct to Xenograft in the Surgical Management of Intrabony Periodontal Defects. A Randomized Controlled Clinical Study
In Brief
A Early Phase 1 clinical trial evaluating particulate xenograft + erythropoietin gel. and particulate xenograft for Periodontal Bone Loss. Completed, enrolled 26 participants across 1 site.
Detailed Summary
The aim of the study is to evaluate the use of erythropoietin gel as an adjunct to xenograft in the surgical management of intrabony periodontal defects.
Study Details
Timeline
Interventions
1. Surgical sites will be anaesthetized using local anaesthesia. 2. Intrasulcular incision will be done in the periodontal pocket as close as possible to the tooth surface with the deepest point being the alveolar crest. 3. The incisions will be extended to the mesial papilla of the tooth before the defect and the distal papilla of the tooth after the defect. 4. Both buccal and lingual/palatal mucoperiosteal flaps will be raised using blunt dissection. 5. Mechanical debridement of the infected tissue from the intrabony defect and root debridement will be done using Gracey curettes. * In Group A (test group): Particulate xenograft will be mixed with EPO gel and applied to fill the whole defect.
* All surgeries will be performed by the same operator as follows: 1. Surgical sites will be anaesthetized using local anaesthesia. 2. Intrasulcular incision will be done in the periodontal pocket as close as possible to the tooth surface with the deepest point being the alveolar crest. 3. The incisions will be extended to the mesial papilla of the tooth before the defect and the distal papilla of the tooth after the defect. 4. Both buccal and lingual/palatal mucoperiosteal flaps will be raised using blunt dissection. 5. Mechanical debridement of the infected tissue from the intrabony defect and root debridement will be done using Gracey curettes. * In Group B (control group): Particulate xenograft will be applied to fill the whole defect.